Pathology and Lab Medicine
Episodes 1-16 of 37
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
- MinuteCE®
Overcoming Acquired TKI-Resistance with Next-generation ROS1-TKI Agents
1.00 program creditCharu Aggarwal, MD, MPH
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
Paul Paik, MD
D. Ross Camidge, MD, PhD
Keith Kerr, BSc, MB ChB
Sara A. Hurvitz, MD, FACP
Sara M. Tolaney MD, MPH
Sara A. Hurvitz, MD, FACP
Sara M. Tolaney MD, MPH
Sara A. Hurvitz, MD, FACP
- MinuteCE®
What Is the Evidence for ADCs in HR-/HER2-Low Metastatic Breast Cancer?
1.00 program creditSara M. Tolaney MD, MPH
- Prev
- Next